Erig Gagne 2

Eric Gagne says 80 percent of his Dodgers teammates used steroids

66 Comments

Former Dodgers closer Eric Gagne has a new biography coming out. And he’s droppin’ bombs: He says that 80 percent of his Dodgers teammates were using PEDS:

In the book, Gagne does not provide any names of players he says used PEDs. Baseball began stricter testing in the spring of 2006. Players are subject to HGH testing during spring training and in the offseason, but not during the season.

“I was intimately aware of the clubhouse in which I lived. I would say that 80 percent of the Dodgers players were consuming them,” Gagne says in the book.

That’s … a lot.

Gagne played for the Dodgers from 1999-2006. His best season — 2003 — came right before the onset of PED testing. On that team was Mitchell Report veterans Paul Lo Duca and Kevin Brown.  Two-time testing loser Guillermo Mota was there too.  There are other interesting names who played on those early 2000s Dodgers teams too, in big and small roles. Many of whom — if they were specifically outed — would create quite an uproar.

If he’s telling the truth it certainly paints an even more stark picture of PED use in that era.  But it also reveals just how unfair it is to single out certain individual players from that era and pretending that they were uniquely villainous.

Report: Tim Lincecum is not ready for retirement

ANAHEIM, CA - JULY 29:  Tim Lincecum #55 of the Los Angeles Angels during the second inning of the game against the Boston Red Sox at Angel Stadium of Anaheim on July 29, 2016 in Anaheim, California.  (Photo by Jayne Kamin-Oncea/Getty Images)
Getty Images
7 Comments

Free agent right-hander Tim Lincecum isn’t ready to hang up his cleats just yet. At least, that’s the word from Lincecum’s agent, Rick Thurman, who says the 32-year-old is still “throwing and getting ready for the season” (via Andrew Baggarly of the San Jose Mercury News).

Lincecum may not be ready to enter retirement, but another quote from Thurman suggests that he’ll be picky about where he pitches next. He doesn’t appear open to pitching overseas, and despite not having a contract for 2017 (or even any serious suitors), the right-hander is set on pitching in the big leagues this year. Whether or not he’s willing to take a bullpen role to do so remains to be seen.

While Baggarly predicts some interest in the veteran righty, there’s not much in Lincecum’s recent history to inspire faith in him as a starter, or even a reliever. He picked up a one-year, $2.5 million contract with the Angels following his hip surgery in 2015, and went 2-6 in 2016 with a 9.16 ERA, 5.4 BB/9 and 7.5 SO/9 over 38 1/3 innings. At this point, a minor league contract seems like the surest path back to major league success, though he’s unlikely to find an open spot on the Giants’ or Angels’ rosters anytime soon.

Report: Jeff Manship signs with NC Dinos

CLEVELAND, OH - NOVEMBER 01:  Jeff Manship #53 of the Cleveland Indians throws a pitch during the sixth inning against the Chicago Cubs in Game Six of the 2016 World Series at Progressive Field on November 1, 2016 in Cleveland, Ohio.  (Photo by Elsa/Getty Images)
Getty Images
1 Comment

Free agent right-hander Jeff Manship has reportedly signed with the NC Dinos of the Korea Baseball Organization, according to FanRag Sports’ Jon Heyman. The righty was non-tendered by the Indians in December.

Manship, 32, completed his second season with Cleveland in 2016. He delivered a 3.12 ERA, 4.6 BB/9 and 7.5 SO/9 rate over 43 1/3 innings, a slight decline after posting an 0.92 ERA with the club the year before. During eight years in the major leagues, Manship carries a 4.82 career ERA, 3.6 BB/9 and 6.4 SO/9 in multiple stints with the Twins, Rockies, Phillies and Indians.

The right-hander will be joined by fellow MLB transplants Eric Hacker and Xavier Scruggs, each of whom took one-year deals with the Dinos last month. Steve Adams of MLB Trade Rumors notes that each KBO team is allowed up to three foreign players, so Manship will round out the trio when he joins the roster. Any salary terms have yet to be disclosed.